{"company": {"org_id": "T004499833", "org_name_cn": "荣昌生物制药(烟台)股份有限公司", "org_short_name_cn": "荣昌生物", "org_name_en": "Remegen Co.,Ltd.", "org_short_name_en": "RemeGen", "main_operation_business": "抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物的研发、生产和销售。", "operating_scope": "　　研发、生产和销售医药产品、诊断试剂产品，以及进行与上述产品及其研发相关的技术服务、技术转让，货物或技术进出口（国家禁止或涉及行政审批的货物和技术进出口除外）（依法须经批准的项目，经相关部门批准后方可开展经营活动）", "district_encode": "370611", "org_cn_introduction": "荣昌生物制药(烟台)股份有限公司的主营业务是抗体药物偶联物（ADC）、抗体融合蛋白、单抗及双抗等治疗性抗体药物的研发、生产和销售。公司的主要产品是泰它西普、维迪西妥单抗、RC28、RC88、RC148、RC278、RC288。泰它西普发明专利先后获得中国、美国、欧洲等国家和地区的授权，得到了国家“十一五”、“十二五”、“十三五”期间“重大新药创制”科技重大专项支持。", "legal_representative": "王威东", "general_manager": "房健民", "secretary": "温庆凯", "established_date": 1215100800000, "reg_asset": 563608243.0, "staff_num": 2999, "telephone": "86-535-3573685", "postcode": "264006", "fax": "86-535-6113517", "email": "ir@remegen.com", "org_website": "www.remegen.cn", "reg_address_cn": "山东省烟台市福山区中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号", "reg_address_en": "58 Middle Beijing Road\r\nYantai Development Zone\r\nYantai Area of Shandong Pilot Free Trade\r\nZone\r\nPRC", "office_address_cn": "山东省烟台市福山区中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号", "office_address_en": "58 Middle Beijing Road\r\nYantai Development Zone\r\nYantai Area of Shandong Pilot Free Trade\r\nZone\r\nPRC", "currency_encode": "019001", "currency": "CNY", "listed_date": 1648656000000, "provincial_name": "山东省", "actual_controller": "房健民 (7.06%)，林健 (2.99%)，王荔强 (1.98%)，王旭东 (1.45%)，邓勇 (1.37%)，王威东 (0.74%)，熊晓滨 (0.38%)，温庆凯 (0.37%)，杨敏华 (0.33%)，魏建良 (0.15%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "王威东", "executives_nums": 10, "actual_issue_vol": 54426301.0, "issue_price": 48.0, "actual_rc_net_amt": 2505945500.0, "pe_after_issuing": null, "online_success_rate_of_issue": 0.03784759, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}}